🇺🇸 FDA
Patent

US 8697858

Antisense antiviral compound and method for treating influenza viral infection

granted A61KA61K31/165A61K31/43

Quick answer

US patent 8697858 (Antisense antiviral compound and method for treating influenza viral infection) held by Sarepta Therapeutics, Inc. expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/165, A61K31/43, A61K31/5377, A61K31/545